Menopausal symptoms among breast cancer patients 6 months after diagnosis: A report from the Shanghai Breast Cancer Survival Study

Menopause

Volumn 16, Issue 6, 2009, Pages 1205-1212

  Dorjgochoo, Tsogzolmaa ^a   Gu, Kai ^b   Kallianpur, Asha ^a   Zheng, Ying ^b   Zheng, Wei ^a   Chen, Zhi ^a   Lu, Wei ^b   Ou Shu, Xiao ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b Shanghai Institute of Preventive Medicine   (China)

Author keywords

Age; Body mass index; Breast cancer; Chemotherapy; Chinese women; Chronic disease; Immunotherapy; Menopausal symptoms; Menopause; Quality of life; Radiotherapy; Tamoxifen

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; INTERFERON; NAVELBINE; TAMOXIFEN; THYMOSIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSAL SYNDROME; MULTIMODALITY CANCER THERAPY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NIGHT SWEAT; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; QUALITY OF LIFE; RISK ASSESSMENT; VAGINAL DRYNESS;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHINA; FEMALE; HOT FLASHES; HUMANS; IMMUNOTHERAPY; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; SWEATING; TAMOXIFEN; TIME FACTORS; VAGINAL DISEASES;

EID: 73249138331     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181aac32b     Document Type: Article

References (43)

1. The North American Menopause Society. Treatment of menopauseassociated vasomotor symptoms: position statement of The North. American Menopause Society. Menopause 2004;11:11-33.
2. Sturdee DW. The menopausal hot flush - anything new?. Maturitas 2008;60:42-49.
3. Umland EM. Treatment strategies for reducing the burden of menopauseassociated vasomotor symptoms. JManag Care Pharm 2008;14:14-19.
4. Williams RE, Kalilani L, DiBenedetti DB, et al. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas 2007;58:348-358.
5. Ganz PA. Menopause and breast cancer: symptoms, late effects, and their management. Semin Oncol 2001;28:274-283.
6. Gupta P, Sturdee DW, Palin SL, et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 2006;9:49-58.
7. McPhail G, Smith LN. Acute menopause symptoms during adjuvant systemic treatment for breast cancer: a case-control study. Cancer Nurs 2000;23:430-443.
8. Crandall C, Petersen. L, Ganz PA, et al. Association, of breast cancer and its therapy with menopause-related symptoms. Menopause 2004; 11: 519-530.
9. Harris PF, Remington. PL, Trentham-Dietz A, et al. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 2002;23:501-509.
10. Osborne CR, Duncan A, Sedlaček S, et al. The addition, of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer. Breast Cancer Res Treat 2009.
11. Carpenter JS, Andrykowski MA. Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum 1999;26:1311-1317.
12. Couzi RJ, Helzlsouer KJ, Fetting JH. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 1995;13:2737-2744.
13. Leining MG, Gelber S, Rosenberg R, et al. Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 2006;17:1777-1782.
14. Duffy CM, Allen SM, Clark MA. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 2005;23:766-773.
15. Ganz PA, Greendale GA, Petersen. L, et al. Breast cancer in younger women: reproductive and late health, effects of treatment. J Clin Oncol 2003;21:4184-4193.
16. Thewes B, Meiser B, Taylor A, et al. Fertility- and menopause-related information needs of younger women with, a diagnosis of early breast cancer. J Clin Oncol 2005;23:5155-5165.
17. Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007;10:197-214.
18. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345-356.
19. Haines CJ, Xing SM, Park KH, et al. Prevalence of menopausal symptoms in different ethnic groups of Asian women, and responsive-ness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Maturitas 2005;52:264-276.
20. Lu W, Cui Y, Chen X, et al. Changes in quality of life among breast cancer patients three years post-diagnosis. Breast Cancer Res Treat 2008;114;357-369.
21. Lu W, Cui Y, Zheng Y, et al. Impact of newly diagnosed breast cancer on quality of life among Chinese women. Breast Cancer Res Treat 2007;102:201-210.
22. Research on the Menopause in the 1990's. Report of a WHO Scientific Group. World Health Organ Tech Rep 1994;866:1-114.
23. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854:1-452.
24. Canney PA, Hatton MQ. The prevalence of menopausal symptoms in patients treated for breast cancer. Clin Oncol (R Coll Radiol) 1994; 6:297-299.
25. Dorjgochoo T, Kallianpur A, Gao YT, et al. Dietary and lifestyle predictors of age at natural menopause and reproductive span in the Shanghai Women's Health Study. Menopause 2008;15:924-933.
26. Goodwin PJ, Ennis M, Pritchard KI, et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999; 17:2365-2370.
27. Knobf MT. The menopausal symptom, experience in young mid-life women, with breast cancer. Cancer Nurs 2001;24:201-210.
28. Day R, Ganz PA, Costantino JP. Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-I) randomized study. J Natl Cancer Inst 2001;93:1615-1623.
29. Land SR, Wickerham DL, Costantino JP, et al. Patient-reported symptoms and quality of life during treatment with tamoxifen, or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295:2742-2751.
30. Carpenter JS, Elam JL, Ridner SH, et al. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 2004;31:591-598.
31. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation. Am J Public Health 2006;96:1226-1235.
32. Schultz PN, Klein MJ, Beck ML, et al. Breast cancer: relationship between, menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. J Clin Nurs 2005;14:204-211.
33. Biglia N, Cozzarella M, Cacciari F, et al. Menopause after breast cancer: a survey on breast cancer survivors. Maturitas 2003;45:29-38.
34. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718-1729.
35. Barbieri RL. Update in female reproduction: a life-cycle approach. J Clin Endocrinol Metab 2008;93:2439-2446.
36. Randolph JF Jr, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005;90: 6106-6112.
37. Gerber B, Dieterich M, Muller H, et al. Controversies in preservation of ovary function and fertility in patients with, breast cancer. Breast Cancer Res Treat 2008;108:1-7.
38. Love RR, Cameron L, Connell BL, et al. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991; 151:1842-1847.
39. Carpenter JS, Andrykowski MA, Cordova M, et al. Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 1998;82:1682-1691.
40. Knobf MT. Physical and psychologic distress associated with adjuvant chemotherapy in women with, breast cancer. J Clin Oncol 1986;4:678-684.
41. Ganz PA, Impact of tamoxifen adjuvant therapy on symptoms, functioning, and quality of life. JNatl Cancer Inst Monogr 2001;130-134.
42. Kenne SE, Ohlen J, Oden A, et al. Experience and predictors of symptoms, distress and health-related quality of life over time in postmenopausal women with, recurrent breast cancer. Psychooncology 2008; 17:497-505.
43. Cronin-Fenton DP, Norgaard M, Jacobsen J, et al. Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer 2007;96:1462-1468.